← 產業報告目錄
Combo IVD Market Size, Share & Trends Analysis Report By Test Type (SARS-CoV-2 Flu A/B Combo Test, COVID-19, Influenza A/B, RSV Combo test, COVID-19 IgM/IgG Combo Test, HIV-1/2 Ag/Ab Combo Test, HIV/Syphilis Ab Combo Test, HIV, HBsAg, HCV & Syphilis Combo, hCG Combo Test, Thrombophilia Detection Combo Test, Other Test Types), By Testing, By End-User, By Channel, By Sample Type, By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-30頁數 180報告編號 INSIGHTACE-9c9173d29c
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Combo IVD Market stood at USD 550.12 Mn in 2023, and is projected to reach USD 920.86 Mn by 2031, recording a CAGR of 6.84% from 2024 through 2031.
Combo IVD covers medical tools that measure and analyze biological samples in a controlled environment. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
The market's upward path is underpinned by expanding healthcare spending, technological evolution, and the expanding focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region projected to deliver the strongest growth trajectory through the forecast period, underpinned by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Combo IVD Market Snapshot
Chapter 4. Global Combo IVD Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Sample Type Estimates & Trend Analysis
5.1. by Sample Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Sample Type:
5.2.1. Orals and Nasal Swabs
5.2.2. Human Serum
5.2.3. Whole Blood
5.2.4. Other Sample Types
Chapter 6. Market Segmentation 2: by Channel Type Estimates & Trend Analysis
6.1. by Channel Type & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Channel Type:
6.2.1. Over-the-Counter
6.2.2. Laboratory based
Chapter 7. Market Segmentation 3: by Test Type Estimates & Trend Analysis
7.1. by Test Type & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Test Type:
7.2.1. SARS-CoV-2 Flu A/B Combo Test
7.2.2. COVID-19, Influenza A/B, RSV Combo test
7.2.3. COVID-19 IgM/IgG Combo Test
7.2.4. HIV-1/2 Ag/Ab Combo Test
7.2.5. HIV/Syphilis Ab Combo Test
7.2.6. HIV, HBsAg, HCV & Syphilis Combo
7.2.7. hCG Combo Test
7.2.8. Thrombophilia Detection Combo Test
7.2.9. Other Test Types
Chapter 8. Market Segmentation 4: by Testing Estimates & Trend Analysis
8.1. by Testing& Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Testing:
8.2.1. Rapid testing
8.2.2. Point of care testing
Chapter 9. Market Segmentation 5: by End-User Estimates & Trend Analysis
9.1. by End-User & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-User;
9.2.1. Diagnostics centres
9.2.2. Hospitals
9.2.3. Homecare setting
9.2.4. Other End-Users
Chapter 10. Combo IVD Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2019-2031
10.1.2. North America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Channel Type, 2019-2031
10.1.3. North America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2019-2031
10.1.4. North America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Testing, 2019-2031
10.1.5. North America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.1.6. North America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.2. Europe
10.2.1. Europe Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2019-2031
10.2.2. Europe Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Channel Type, 2019-2031
10.2.3. Europe Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2019-2031
10.2.4. Europe Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Testing, 2019-2031
10.2.5. Europe Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.2.6. Europe Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2019-2031
10.3.2. Asia Pacific Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Channel Type, 2019-2031
10.3.3. Asia-Pacific Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2019-2031
10.3.4. Asia Pacific Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Testing, 2019-2031
10.3.5. Asia Pacific Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.3.6. Asia Pacific Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
10.4. Latin America
10.4.1. Latin America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2019-2031
10.4.2. Latin America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Channel Type, 2019-2031
10.4.3. Latin America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2019-2031
10.4.4. Latin America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Testing, 2019-2031
10.4.5. Latin America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.4.6. Latin America Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2019-2031
10.5.2. Middle East & Africa Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Channel Type, 2019-2031
10.5.3. Middle East & Africa Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2019-2031
10.5.4. Middle East & Africa Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by Testing, 2019-2031
10.5.5. Middle East & Africa Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
10.5.6. Middle East & Africa Combo IVD Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. DRG International Inc.
11.2.2. Becton, Dickinson and Company
11.2.3. DiaCarta Inc
11.2.4. Abbott
11.2.5. bioMérieux SA4
11.2.6. Bio-Rad Laboratories
11.2.7. Alpha IVD Srl
11.2.8. BioGX BV
11.2.9. Thermo Fisher Scientific Inc.
11.2.10. Megna Health Inc
11.2.11. CTK Biotech, Inc.
11.2.12. Biopanda Reagents Ltd
11.2.13. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們